Nutex Health Inc.
For the period ended Mar 31, 2026. Filed Apr 30, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed Apr 30, 2026
NUTX$186.25-4.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets (unaudited)
| (In thousands, except share and per share amounts) | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $207,347 | $185,574 |
| Restricted cash | 3,292 | 297 |
| Accounts receivable | 339,560 | 319,440 |
| Accounts receivable - related parties | 6,339 | 5,978 |
| Inventories | 4,679 | 2,866 |
| Prepaid expenses and other current assets | 18,432 | 24,656 |
| Total current assets | 579,649 | 538,811 |
| Property and equipment, net (accumulated depreciation of 33,598 and 31,696 as of March 31, 2026 and December 31, 2025, respectively) | 94,927 | 94,581 |
| Operating lease right-of-use assets | 26,554 | 26,955 |
| Financing lease right-of-use assets | 220,696 | 222,367 |
| Intangible assets, net | 20,905 | 21,230 |
| Goodwill, net | 13,919 | 13,919 |
| Other assets | 668 | 662 |
| Total assets | $957,318 | $918,525 |
| Liabilities and Equity | ||
| Current liabilities: | ||
| Accounts payable | $46,452 | $45,863 |
| Accounts payable - related parties | 3,920 | 3,104 |
| Lines of credit | 146 | 740 |
| Current portion of long-term debt | 16,728 | 13,336 |
| Operating lease liabilities, current portion | 2,176 | 2,152 |
| Financing lease liabilities, current portion | 7,364 | 7,077 |
| Accrued arbitration expenses | 56,833 | 49,743 |
| Accrued income tax expense | 15,594 | 867 |
| Accrued stock-based compensation | 2,723 | 8,256 |
| Accrued expenses and other current liabilities | 32,500 | 26,773 |
| Total current liabilities | 184,436 | 157,911 |
| Long-term debt, net | 24,261 | 29,174 |
| Non-current operating lease liabilities, net | 29,633 | 30,037 |
| Non-current financing lease liabilities, net | 268,778 | 268,877 |
| Deferred tax liabilities | 8,157 | 9,089 |
| Total liabilities | 515,265 | 495,088 |
| Commitments and contingencies (Note 10) | ||
| Equity: | ||
| Common stock, $0.001 par value; 950,000,000 shares authorized; 6,951,622 and 7,086,670 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 7 | 7 |
| Additional paid-in capital | 585,666 | 615,627 |
| Accumulated deficit | (239,380) | (286,187) |
| Nutex Health Inc. equity | 346,293 | 329,447 |
| Noncontrolling interests | 95,760 | 93,990 |
| Total equity | 442,053 | 423,437 |
| Total liabilities and equity | $957,318 | $918,525 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.